Sales Projections for Xyosted Xyosted just completed its sixth full quarter of sales since its launch in 4Q, 2018. Almost all product launches are difficult in this managed care environment. It often takes a year or so to get reimbursement issues partially resolved. Just as Xyosted got through this, the launch ran smack into the […]
Welcome to SmithonStocks (SOS), home to in-depth financial analysis and research reports with a focus on emerging biotechnology companies.
You now must be a subscriber in order to gain full access to new and featured reports. Please click the "Subscribe" button to register for a SoS subscription. If you are already have a SoS subscription account please log in now.
As always, all blog posts and old reports do not require a subscription to read.
Thank you for visiting SmithonStocks.com.